Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.915 USD | -1.31% | +0.38% | +148.61% |
10/04 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
18/03 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+148.61% | 927M | |
+3.80% | 108B | |
+11.01% | 104B | |
+1.28% | 22.33B | |
-12.89% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.45% | 17.64B | |
+3.73% | 14.05B | |
+36.51% | 12.51B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Morgan Stanley Adjusts Arcutis Biotherapeutics' Price Target to $49 from $46, Maintains Overweight Rating